A hospital's evidence-based medicine committee is reviewing a series of novel diagnostic assays for infectious diseases. To standardize interpretation across the health system, they are categorizing tests based on their likelihood ratios (LR). Match each likelihood ratio profile with its corresponding qualitative impact on the post-test probability of disease.
- A diagnostic test yielding a Positive Likelihood Ratio (LR+) > 10Generates a large and often conclusive increase in the post-test probability of disease
- A diagnostic test yielding a Positive Likelihood Ratio (LR+) between 1.1 and 2.0Generates a small, rarely clinically meaningful increase in the post-test probability of disease
- A diagnostic test yielding a Negative Likelihood Ratio (LR-) < 0.1Generates a large and often conclusive decrease in the post-test probability of disease
- A diagnostic test yielding a Negative Likelihood Ratio (LR-) between 0.5 and 0.9Generates a small, rarely clinically meaningful decrease in the post-test probability of disease
Answer
The correct matching pairs likelihood ratios with their established qualitative effects on post-test probability: LR+ > 10 produces large, conclusive increases; LR+ 1.1-2.0 produces negligible increases; LR- < 0.1 produces large, conclusive decreases; and LR- 0.5-0.9 produces negligible decreases.
Likelihood ratios (LRs) are critical for evidence-based diagnosis because, unlike predictive values, they are independent of the underlying disease prevalence in the tested population. They allow clinicians to estimate post-test probability using Fagan's nomogram or approximation heuristics. By established standards, an LR+ > 10 increases probability by roughly 45%, providing strong, often conclusive evidence to rule in a diagnosis. Conversely, an LR- < 0.1 decreases probability by roughly 45%, providing strong evidence to rule out a diagnosis. Likelihood ratios approaching 1 (such as LR+ 1.1-2.0 or LR- 0.5-0.9) indicate that the test result is almost equally likely to occur in patients with and without the disease, thereby providing minimal to no clinically meaningful shift in probability.
Step-by-Step Solution
Key Concept
Interpretation of Likelihood Ratios